This nasal spray vaccine can be self-administered or given by a caregiver, potentially increasing vaccination rates and accessibility.
Raanana, Israel - Polyrizon Ltd. (NASDAQ:PLRZ), a biotech firm in the development stage, has filed a divisional patent application in Israel for its Trap & Target (NYSE:TGT) (T&T) platform technology.
Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced the filing of a ...
The “life-changing” drug, Acarizax, works by delivering a fixed amount of house dust mite allergy extract every day to help ...